• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受使用动静脉内瘘进行延长间歇性肾脏替代治疗(PIRRT)的维持性血液透析患者的长期动静脉内瘘预后。

Long-term arteriovenous fistula prognosis for maintenance hemodialysis patients who accepted PIRRT by using arteriovenous fistula.

作者信息

Wei Suijiao, Jiao Jing, Yu Yan, Tian Xiujuan, Yang Xiaoxia, Feng Shidong, Li Yajuan, Zhang Peng, Bai Ming

机构信息

The Department of Nephrology, Xijing Hospital, the Fourth Military Medical University, Xi'an, Shaanxi, China.

Xi'an Medical University, Xi'an, Shaanxi, China.

出版信息

Int J Artif Organs. 2023 Apr;46(4):195-201. doi: 10.1177/03913988231162384. Epub 2023 Mar 21.

DOI:10.1177/03913988231162384
PMID:36945121
Abstract

BACKGROUND

Maintenance hemodialysis (MHD) patients are often admitted to the hospital for severe morbidities. Prolonged intermittent renal replacement therapy (PIRRT) is required during the hospital staying. There are controversial opinions on the use of arteriovenous fistula (AVF) as vascular access for PIRRT in MHD patients.

METHODS

Patients with AVF who accepted PIRRT in our center between January 2014 and June 2021 were retrospectively screened. AVF dysfunction and patient mortality were assessed as endpoints. Univariate and multivariate regression models were employed to identify the risk factors of AVF dysfunction.

RESULTS

About 162 patients were included in our present study. Twenty-six experienced AVF dysfunction, of whom 53.8%, 19.2%, and 27.0% had percutaneous transluminal balloon angioplasty, surgical revision, and AVF reconstruction, respectively. The accumulated AVF dysfunction rates were 11.8%, 16.2%, and 21.0% in 1, 2, and 3 years, respectively. Multivariate analysis revealed that smoking (HR 2.750, 95% CI 1.181-6.402,  = 0.019), higher platelet (PLT, HR 1.009, 95% CI 1.000-1.017,  = 0.047), higher prothrombin activity (PTA, HR 1.039, 95% CI 1.012-1.066,  = 0.004), and lower diastolic blood pressure (DBP, HR 0.963, 95% CI 0.932-0.996,  = 0.026) were independent risk factors for AVF dysfunction. During the follow-up period, 37 patients died.

CONCLUSIONS

Overall, the use of AVF for PIRRT might not dramatically increase the incidence of AVF dysfunction. And, Smoking, lower DBP, higher PLT, and higher PTA were associated with increased AVF dysfunction.

摘要

背景

维持性血液透析(MHD)患者常因严重疾病入院。住院期间需要进行延长的间歇性肾脏替代治疗(PIRRT)。对于动静脉内瘘(AVF)作为MHD患者PIRRT的血管通路的使用存在争议。

方法

回顾性筛选2014年1月至2021年6月在本中心接受PIRRT的AVF患者。评估AVF功能障碍和患者死亡率作为终点。采用单因素和多因素回归模型确定AVF功能障碍的危险因素。

结果

本研究共纳入约162例患者。26例出现AVF功能障碍,其中分别有53.8%、19.2%和27.0%的患者接受了经皮腔内球囊血管成形术、手术修复和AVF重建。1年、2年和3年的累积AVF功能障碍发生率分别为11.8%、16.2%和21.0%。多因素分析显示,吸烟(HR 2.750,95%CI 1.181 - 6.402,P = 0.019)、较高的血小板计数(PLT,HR 1.009,95%CI 1.000 - 1.017,P = 0.047)、较高的凝血酶原活性(PTA,HR 1.039,95%CI 1.012 - 1.066,P = 0.004)以及较低的舒张压(DBP,HR 0.963,95%CI 0.932 - 0.996,P = 0.026)是AVF功能障碍的独立危险因素。随访期间,37例患者死亡。

结论

总体而言,将AVF用于PIRRT可能不会显著增加AVF功能障碍的发生率。并且,吸烟、较低的DBP、较高的PLT和较高的PTA与AVF功能障碍增加有关。

相似文献

1
Long-term arteriovenous fistula prognosis for maintenance hemodialysis patients who accepted PIRRT by using arteriovenous fistula.接受使用动静脉内瘘进行延长间歇性肾脏替代治疗(PIRRT)的维持性血液透析患者的长期动静脉内瘘预后。
Int J Artif Organs. 2023 Apr;46(4):195-201. doi: 10.1177/03913988231162384. Epub 2023 Mar 21.
2
Factors associated with dysfunction of autogenous arteriovenous fistula in patients with maintenance hemodialysis: a retrospective study.维持性血液透析患者自体动静脉内瘘功能障碍的相关因素:一项回顾性研究
Ann Palliat Med. 2021 Apr;10(4):4047-4054. doi: 10.21037/apm-20-2196. Epub 2021 Mar 23.
3
The efficacy of percutaneous transluminal angioplasty for the endovascular management of arteriovenous fistula dysfunction: a retrospective analysis in patients with end-stage renal disease.经皮腔内血管成形术治疗动静脉瘘功能障碍的疗效:终末期肾病患者的回顾性分析。
Int Angiol. 2020 Aug;39(4):341-348. doi: 10.23736/S0392-9590.20.04334-5. Epub 2020 Apr 16.
4
The risk factors for arteriovenous fistula dysfunction in maintenance hemodialysis patients: A cross-sectional study.维持性血液透析患者动静脉瘘功能障碍的危险因素:一项横断面研究。
Hemodial Int. 2024 Apr;28(2):170-177. doi: 10.1111/hdi.13145. Epub 2024 Mar 6.
5
Factors affecting patency of arteriovenous fistula following first percutaneous transluminal angioplasty.影响初次经皮腔内血管成形术后动静脉瘘通畅的因素。
Clin Exp Nephrol. 2021 Jan;25(1):80-86. doi: 10.1007/s10157-020-01958-w. Epub 2020 Aug 27.
6
Tradeoffs in Vascular Access Selection in Elderly Patients Initiating Hemodialysis With a Catheter.老年血液透析患者导管置管时血管通路选择的权衡。
Am J Kidney Dis. 2018 Oct;72(4):509-518. doi: 10.1053/j.ajkd.2018.03.023. Epub 2018 May 18.
7
Arteriovenous Vascular Access-Related Procedural Burden Among Incident Hemodialysis Patients in the United States.美国新进入血液透析患者的动静脉血管通路相关程序性负担。
Am J Kidney Dis. 2021 Sep;78(3):369-379.e1. doi: 10.1053/j.ajkd.2021.01.019. Epub 2021 Apr 20.
8
Morphological Lesion Types Are Associated with Primary and Secondary Patency Rates after High-Pressure Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas.形态学病变类型与高压球囊血管成形术治疗功能不良动静脉瘘后的原发性和继发性通畅率相关。
Blood Purif. 2022;51(5):425-434. doi: 10.1159/000516883. Epub 2021 Jul 28.
9
Assessment of Use of Arteriovenous Graft vs Arteriovenous Fistula for First-time Permanent Hemodialysis Access.评估动静脉移植物与动静脉瘘在首次永久性血液透析通路中的应用。
JAMA Surg. 2019 Sep 1;154(9):844-851. doi: 10.1001/jamasurg.2019.1736.
10
Arteriovenous fistula formation with adjuvant endovascular maturation.动静脉瘘形成伴辅助血管腔内成熟。
J Vasc Surg. 2022 Feb;75(2):641-650.e2. doi: 10.1016/j.jvs.2021.08.072. Epub 2021 Sep 8.

引用本文的文献

1
Retrospective analysis of predictive factors for AVF dysfunction in patients undergoing MHD.维持性血液透析患者动静脉内瘘功能障碍的预测因素回顾性分析。
Medicine (Baltimore). 2024 Apr 19;103(16):e37737. doi: 10.1097/MD.0000000000037737.